The Pharmaceutical Contract Manufacturing Services industry on FinBizNet covers 26 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 26 |
|---|---|
| Combined market cap | ₹2,19,912 Cr |
| Median P/E (profitable companies) | 29.5 |
| Median return on equity | 2.9% |
| Companies with latest quarterly results | 13 of 26 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,70,481 Cr | 70.1 | 17.0% | ₹4,979 Cr | ₹534 Cr | Q2 FY27 |
| Aether Industries Limited | ₹18,748 Cr | 85.4 | 9.8% | ₹327 Cr | ₹63 Cr | Q1 FY27 |
| Alivus Life Sciences Ltd | ₹15,350 Cr | 27.2 | 18.4% | ₹640 Cr | ₹160 Cr | Q1 FY27 |
| Aarti Pharmalabs Ltd | ₹7,443 Cr | 42.6 | 8.5% | ₹536 Cr | ₹69 Cr | Q1 FY27 |
| Solara Active Pharma Sciences Limited | ₹2,951 Cr | — | -0.6% | ₹417 Cr | ₹28 Cr | Q2 FY27 |
| Sai Parenteral's Limited | ₹2,040 Cr | 105.9 | 2.9% | ₹179 Cr | ₹8 Cr | Q1 FY27 |
| KRM Ayurveda Limited | ₹508 Cr | 25.2 | — | ₹32 Cr | ₹9 Cr | Q1 FY27 |
| Trident Lifeline Limited | ₹486 Cr | 24.9 | — | — | — | — |
| Infinium Pharmachem Limited | ₹446 Cr | 36.7 | — | — | — | — |
| Accretion Nutraveda Limited | ₹198 Cr | 29.2 | — | — | — | — |
| Bio Medica Laboratories Limited | ₹188 Cr | 11.7 | — | — | — | — |
| Sanjivani Paranteral Ltd. | ₹188 Cr | 27.5 | 14.8% | ₹19 Cr | ₹2 Cr | Q1 FY27 |
| Curis Lifesciences Limited | ₹143 Cr | — | — | — | — | — |
| Quest Laboratories Limited | ₹134 Cr | 9.0 | 16.8% | ₹32 Cr | ₹3 Cr | Q4 FY26 |
| Pharmaids Pharmaceuticals Ltdte | ₹102 Cr | — | -17.8% | ₹0 Cr | ₹2 Cr | Q1 FY27 |
| Concord Drugs Ltd | ₹90 Cr | 71.9 | 2.6% | — | — | — |
| Denis Chem Lab Ltd | ₹83 Cr | — | — | ₹44 Cr | ₹2 Cr | Q1 FY27 |
| Cian Healthcare Ltd | ₹76 Cr | — | -57.3% | — | — | — |
| Onyx Biotec Limited | ₹67 Cr | — | — | — | — | — |
| Rekvina Laboratories Ltd | ₹62 Cr | — | — | — | — | — |
| Vivimed Labs Ltd. | ₹50 Cr | — | — | ₹12 Cr | ₹-146 Cr | Q4 FY26 |
| Medicamen Organics Limited | ₹30 Cr | — | — | — | — | — |
| Zenith Healthcare Ltd | ₹17 Cr | 3190.0 | 0.1% | ₹3 Cr | ₹0 Cr | Q1 FY27 |
| Norris Medicines Ltd. | ₹15 Cr | — | 1.9% | — | — | — |
| Beryl Drugs Ltd. | ₹13 Cr | 29.5 | 4.4% | — | — | — |
| Evoq Remedies Ltd | ₹5 Cr | — | -0.5% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 26 listed companies in the Pharmaceutical Contract Manufacturing Services industry, including Torrent Pharma Ltd., Aether Industries Limited, Alivus Life Sciences Ltd, Aarti Pharmalabs Ltd, Solara Active Pharma Sciences Limited, Sai Parenteral's Limited, KRM Ayurveda Limited, Trident Lifeline Limited, among others.
By market capitalisation, the largest Pharmaceutical Contract Manufacturing Services companies are Torrent Pharma Ltd. (₹1,70,481 Cr), Aether Industries Limited (₹18,748 Cr), Alivus Life Sciences Ltd (₹15,350 Cr), Aarti Pharmalabs Ltd (₹7,443 Cr), Solara Active Pharma Sciences Limited (₹2,951 Cr).
The 26 Pharmaceutical Contract Manufacturing Services companies tracked on FinBizNet have a combined market capitalisation of about ₹2,19,912 Cr.
The median price-to-earnings ratio across 15 profitable Pharmaceutical Contract Manufacturing Services companies is 29.5, and the median return on equity across the industry is 2.9%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical Contract Manufacturing Services industry.